相关实验视频

Updated: May 11, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

纽约州围产期毒理学实践的多层次解释顺序混合方法研究:协议

Sugy Choi¹, Elizabeth Knopf¹, Erin Kim¹

¹Department of Population Health, New York University Grossman School of Medicine, New York, New York, United States of America.

|December 31, 2025

概括

孕产妇过量服用药物的死亡率正在上升,特别是在孕妇中. 本研究研究了毒理学测试变异和结果,以改善护理准入,减少孕妇和产后患者之间的差异.

科学领域:

公共卫生公共卫生
医疗保健服务研究医疗服务研究
孕产妇健康孕产妇健康

背景情况:

药物过量导致的孕产妇发病率和死亡率 (MMM) 的上升影响了35-44岁的孕妇和产后妇女.
医院当前的毒理学检测实践缺乏对其有效性在将患者与护理联系起来方面的明确理解.
在脆弱的孕产妇人群中,护理准入方面的差异仍然存在.

研究的目的:

调查怀孕和产后妇女的毒理学测试的变化.
探索影响测试实践的医院和个人层面的因素.
评估测试对护理和健康结果的联系的影响.

主要方法:

使用纽约州卫生服务差异研究的社会文化框架 (SCF-HSD) 进行混合方法研究.
多层统计模型与纽约州医疗补助申请数据 (2021-2024) 识别测试预测因素和医院变异.
与医院工作人员进行定性访谈,并与有实践经验的个人聚焦小组,以告知政策.

主要成果:

将确定围产期毒理学测试的预测因素.
在测试政策和实践中,医院一级的变化将是特征.
将捕捉到对测试理性,态度和坚持的不同观点.

结论:

结果将指导改善对孕妇和产后妇女的毒理学测试差异.
强调标准化,基于证据的协议和支持性服务途径至关重要.
政策改革是必要的,以减少在孕产妇护理中的耻辱和不平等.

更多相关视频

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes

Published on: June 28, 2024

相关概念视频

Toxicity Testing in Animals

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...